All In Biotech

Drug Trial Radar · NCT07573631

An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy

An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Weekly Intravenous Infusions of BMN 351 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Last checked: Nov 19, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

18

Planned (sponsor's estimate)

Start

Apr 20, 2026

Primary completion

Dec 2031

Study completion Dec 2031

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
May 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This open-label extension study aims to evaluate the long-term safety and tolerability of weekly BMN 351 infusions, as well as to assess the effect of BMN 351 on physical function, in participants with DMD who participated in the 351-201 study.

Conditions

  • Duchenne Muscular Dystrophy (DMD)

Interventions

  • BMN 351Drug

    Anti-sense Oligonucleotide BMN 351 will be administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the long-term safety and tolerability of BMN 351 in participants with DMDTime frame: Through study completion, at least 1 year

Locations

6 sites in 5 countries. Site status is shown where the registry gives one.

  • Fondazione Serena ETS - Centro Clinico NeMO Milano

    Milan, Italy, Italy

  • UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore

    Rome, Italy, Italy

  • Leids Universitair Medisch Centrum

    Leiden, Netherlands, Netherlands

  • Hospital Viamed Santa Angela De la Cruz

    Seville, Spain, Spain

  • Yeditepe University Kosuyolu Hospital

    Istanbul, Turkey, Turkey (Türkiye)

  • Great Ormond Street Hospital NHS Foundation Trust

    London, United Kingdom, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.